Literature DB >> 9393281

Risk factors for surgical treatment in the Dutch Gastric Cancer Trial.

M Sasako1.   

Abstract

BACKGROUND: A multicentre randomized study of surgical treatment of gastric cancer has shown increased mortality and morbidity rates in patients having D2 resection. The aim of this report is to analyse risk factors in these patients.
METHODS: In a prospective randomized trial, comparing two types of lymphadenectomy for curable gastric cancer, risk factors for hospital death and morbidity in 711 patients treated with curative intent were evaluated by multivariate analysis using stepwise regression analysis.
RESULTS: Age greater than 65 years and male sex were the most important risk factors for death (relative risk (RR) 4.35 (95 per cent confidence interval (c.i.) 2.07-9.15) and 2.51 (95 per cent c.i. 1.24-5.08) respectively). The extent of nodal dissection was also a significant risk factor for death (RR 2.13). For overall complications, splenectomy was the most important risk factor (RR 2.13 (95 per cent c.i. 1.44-3.16)), while pancreatectomy and type of gastrectomy were the only factors significantly influencing the occurrence of major surgical complications.
CONCLUSION: The cumulative mortality risks of these factors should be considered carefully when planning surgery for individual patients.

Entities:  

Mesh:

Year:  1997        PMID: 9393281     DOI: 10.1111/j.1365-2168.1997.02842.x

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  54 in total

Review 1.  Management of upper gastrointestinal cancers.

Authors:  A Melville; E Morris; D Forman; A Eastwood
Journal:  Qual Health Care       Date:  2001-03

2.  The evaluation of surgical treatment for gastric cancer patients with noncurative resection.

Authors:  Teiji Naka; Makoto Iwahashi; Mikihito Nakamori; Masaki Nakamura; Toshiyasu Ojima; Takeshi Iida; Masahiro Katsuda; Tsuji Toshiaki; Hayata Keiji; Hiroki Yamaue
Journal:  Langenbecks Arch Surg       Date:  2012-08       Impact factor: 3.445

3.  Risk factors for surgical site infections after elective gastrectomy.

Authors:  Kazuhiro Migita; Tomoyoshi Takayama; Sohei Matsumoto; Kohei Wakatsuki; Koji Enomoto; Tetsuya Tanaka; Masahiro Ito; Yoshiyuki Nakajima
Journal:  J Gastrointest Surg       Date:  2012-02-15       Impact factor: 3.452

4.  A feasibility study on the expanded indication for endoscopic submucosal dissection of early gastric cancer.

Authors:  Hyuk Lee; Won Kyoung Yun; Byung-Hoon Min; Jun Haeng Lee; Poong-Lyul Rhee; Kyoung Mee Kim; Jong Chul Rhee; Jae J Kim
Journal:  Surg Endosc       Date:  2010-12-07       Impact factor: 4.584

5.  Multiorgan resection for gastric cancer: intraoperative and computed tomography assessment of locally advanced disease is inaccurate.

Authors:  Kari L Colen; Stuart G Marcus; Elliot Newman; Russell S Berman; Herman Yee; Spiros P Hiotis
Journal:  J Gastrointest Surg       Date:  2004-11       Impact factor: 3.452

6.  Complications following D3 gastrectomy: post hoc analysis of a randomized trial.

Authors:  Chew-Wun Wu; I-Shou Chang; Su-shun Lo; Mao-Chin Hsieh; Jen-Hao Chen; Wing-Yiu Lui; Jacqueline Whang-Peng
Journal:  World J Surg       Date:  2006-01       Impact factor: 3.352

7.  Risk factors related to operative morbidity in patients undergoing gastrectomy for gastric cancer.

Authors:  A Gil-Rendo; J L Hernández-Lizoain; F Martínez-Regueira; A Sierra Martínez; F Rotellar Sastre; M Cervera Delgado; V Valentí Azcarate; C Pastor Idoate; J Alvarez-Cienfuegos
Journal:  Clin Transl Oncol       Date:  2006-05       Impact factor: 3.405

Review 8.  Endoscopic resection of early gastric cancer.

Authors:  Takuji Gotoda
Journal:  Gastric Cancer       Date:  2007-02-23       Impact factor: 7.370

9.  Laparoscopic gastrectomy for gastric cancer: early experience among the elderly.

Authors:  K K Singh; A Rohatgi; Iryna Rybinkina; Peter McCulloch; Satvinder Mudan
Journal:  Surg Endosc       Date:  2007-09-02       Impact factor: 4.584

10.  Results of R0 surgery with D2 lymphadenectomy for the treatment of localised gastric cancer.

Authors:  A Díaz de Liaño; C Yárnoz; C Artieda; R Aguilar; S Viana; A Artajona; H Ortiz
Journal:  Clin Transl Oncol       Date:  2009-03       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.